Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.
Publication/Presentation Date
4-1-2017
Volume
35
Issue
2
First Page
90
Last Page
95
ISSN
0891-8929
Published In/Presented At
Warren, M. L., Chaykin, L. B., Jabbour, S., Sheikh-Ali, M., Hansen, C. T., Nielsen, T. S. S., & Norwood, P. (2017). Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin. Clinical diabetes : a publication of the American Diabetes Association, 35(2), 90–95. https://doi.org/10.2337/cd15-0058
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
28442823
Department(s)
Administration and Leadership
Document Type
Article
COinS